Scott Ayton

15.5k total citations · 11 hit papers
129 papers, 8.5k citations indexed

About

Scott Ayton is a scholar working on Physiology, Molecular Biology and Nutrition and Dietetics. According to data from OpenAlex, Scott Ayton has authored 129 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Physiology, 39 papers in Molecular Biology and 35 papers in Nutrition and Dietetics. Recurrent topics in Scott Ayton's work include Alzheimer's disease research and treatments (52 papers), Trace Elements in Health (35 papers) and Parkinson's Disease Mechanisms and Treatments (24 papers). Scott Ayton is often cited by papers focused on Alzheimer's disease research and treatments (52 papers), Trace Elements in Health (35 papers) and Parkinson's Disease Mechanisms and Treatments (24 papers). Scott Ayton collaborates with scholars based in Australia, United States and China. Scott Ayton's co-authors include Ashley I. Bush, Peng Lei, Paul A. Adlard, David I. Finkelstein, James A. Duce, Abdel Ali Belaidi, Ibrahima Diouf, Dominic J. Hare, Darius J.R. Lane and Irene Volitakis and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Scott Ayton

123 papers receiving 8.4k citations

Hit Papers

Tau-mediated iron export prevents ferroptotic damage aft... 2012 2026 2016 2021 2017 2018 2012 2018 2020 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tau-mediated iron export prevents ferroptotic damage after ischemic stroke
    2017 550 citations Peng Lei, Scott Ayton et al. Molecular Psychiatry profile →
  2. Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
    2018 525 citations Denzil Furtado, Mattias Björnmalm et al. Advanced Materials profile →
  3. Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export
    2012 472 citations Peng Lei, Scott Ayton et al. profile →
  4. Current state of Alzheimer’s fluid biomarkers
    2018 375 citations Scott Ayton et al. profile →
  5. Ferroptosis and its potential role in the physiopathology of Parkinson’s Disease
    2020 367 citations Scott Ayton et al. profile →
  6. Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology
    2019 290 citations Scott Ayton, Julie A. Schneider et al. Molecular Psychiatry profile →
  7. The essential elements of Alzheimer’s disease
    2020 217 citations Peng Lei, Scott Ayton et al. Journal of Biological Chemistry profile →
  8. Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease
    2021 141 citations Md. Jakaria, Abdel Ali Belaidi et al. Journal of Neurochemistry profile →
  9. Ferroptosis promotes T-cell activation-induced neurodegeneration in multiple sclerosis
    2022 126 citations Scott Ayton, Peng Lei et al. profile →
  10. Accelerated Brain Volume Loss Caused by Anti–β-Amyloid Drugs
    2023 122 citations Francesca Alves, Paweł Kalinowski et al. profile →
  11. In defence of ferroptosis
    2025 38 citations Francesca Alves, Darius J.R. Lane et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott Ayton Australia 47 3.0k 2.6k 2.2k 1.6k 1.4k 129 8.5k
James A. Duce Australia 34 1.8k 0.6× 1.5k 0.6× 752 0.3× 1.0k 0.6× 453 0.3× 62 4.4k
Zvonimir S. Katušić United States 62 3.7k 1.2× 5.6k 2.2× 1.0k 0.5× 436 0.3× 400 0.3× 230 11.9k
Irene Volitakis Australia 44 2.6k 0.8× 4.8k 1.9× 395 0.2× 3.6k 2.2× 450 0.3× 87 8.8k
Jack T. Rogers United States 52 3.1k 1.0× 3.9k 1.5× 292 0.1× 1.8k 1.1× 471 0.3× 122 9.1k
Masatsugu Horiuchi Japan 67 5.8k 1.9× 1.9k 0.7× 599 0.3× 561 0.3× 571 0.4× 267 14.3k
Robert D. Bell United States 33 3.2k 1.1× 3.8k 1.5× 372 0.2× 472 0.3× 754 0.6× 53 9.9k
Junxia Xie China 45 1.7k 0.6× 780 0.3× 623 0.3× 926 0.6× 236 0.2× 157 5.0k
Mark A. Lovell United States 56 5.5k 1.8× 6.2k 2.4× 314 0.1× 2.3k 1.5× 417 0.3× 109 12.4k
Zhong‐Ming Qian China 45 2.1k 0.7× 716 0.3× 408 0.2× 1.7k 1.0× 432 0.3× 154 7.1k
Ya Ke Hong Kong 43 1.3k 0.4× 904 0.4× 340 0.2× 1.3k 0.8× 462 0.3× 133 5.3k

Countries citing papers authored by Scott Ayton

Since Specialization
Citations

This map shows the geographic impact of Scott Ayton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Ayton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Ayton more than expected).

Fields of papers citing papers by Scott Ayton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Ayton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Ayton. The network helps show where Scott Ayton may publish in the future.

Co-authorship network of co-authors of Scott Ayton

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Ayton. A scholar is included among the top collaborators of Scott Ayton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Ayton. Scott Ayton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alves, Francesca, et al.. (2025). In defence of ferroptosis. Signal Transduction and Targeted Therapy. 10(1). 2–2. 38 indexed citations breakdown →
2.
Alves, Francesca, Darius J.R. Lane, Adam Wahida, et al.. (2025). Aberrant Mitochondrial Metabolism in Alzheimer's Disease Links Energy Stress with Ferroptosis. Advanced Science. 12(37). e04175–e04175. 5 indexed citations
3.
Guan, Xiaojun, et al.. (2024). Neuroimaging of Parkinson's disease by quantitative susceptibility mapping. NeuroImage. 289. 120547–120547. 28 indexed citations
4.
Chalmers, David K., et al.. (2024). The 8-hydroxyquinoline derivative, clioquinol, is an alpha-1 adrenoceptor antagonist. Biochemical Pharmacology. 222. 116092–116092. 4 indexed citations
5.
Belaidi, Abdel Ali, Ashley I. Bush, & Scott Ayton. (2024). Apolipoprotein E and Apolipoprotein E receptor 2 signaling as drug targets in Alzheimer’s disease. Alzheimer s & Dementia. 20(S1). e086014–e086014. 1 indexed citations
6.
7.
Hung, Ya Hui, Abdel Ali Belaidi, Irene Volitakis, et al.. (2024). Impaired cellular copper regulation in the presence of ApoE4. Journal of Neurochemistry. 168(9). 3284–3307. 1 indexed citations
8.
Fazlollahi, Amir, Rishma Vidyasagar, Scott Ayton, et al.. (2024). Quantitative susceptibility mapping of the fear circuit: Associations with silent symptoms in relapsing-remitting multiple sclerosis. The Neuroradiology Journal. 38(4). 464–474.
9.
Vidyasagar, Rishma, et al.. (2024). Single‐session reproducibility of MR spectroscopy measures of glutathione in the mesial temporal lobe with MEGA‐PRESS. Journal of Neuroimaging. 34(2). 224–231. 1 indexed citations
10.
Marmolejo-Garza, Alejandro, Marina Trombetta-Lima, Tamara Tomin, et al.. (2024). The link between amyloid β and ferroptosis pathway in Alzheimer’s disease progression. Cell Death and Disease. 15(10). 782–782. 20 indexed citations
11.
Lim, Yen Ying, Nawaf Yassi, Scott Ayton, et al.. (2023). CSF Aβ42 and tau biomarkers in cognitively unimpaired Aβ- middle-aged and older APOE ε4 carriers. Neurobiology of Aging. 129. 209–218. 7 indexed citations
12.
Ma, Shuai, Connie P. C. Ow, Roger G. Evans, et al.. (2023). Renal arterial infusion of tempol prevents medullary hypoperfusion, hypoxia, and acute kidney injury in ovine Gram‐negative sepsis. Acta Physiologica. 239(1). e14025–e14025. 7 indexed citations
13.
Liu, Kathy, Nicolas Villain, Scott Ayton, et al.. (2023). Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer’s disease. Brain Communications. 5(3). fcad175–fcad175. 32 indexed citations
14.
Lotan, Amit, Sandra Luza, Carlos Opazo, et al.. (2023). Perturbed iron biology in the prefrontal cortex of people with schizophrenia. Molecular Psychiatry. 28(5). 2058–2070. 26 indexed citations
15.
Mandal, Pravat K., Ashley I. Bush, Manjari Tripathi, et al.. (2022). Hippocampal glutathione depletion with enhanced iron level in patients with mild cognitive impairment and Alzheimer’s disease compared with healthy elderly participants. Brain Communications. 4(5). fcac215–fcac215. 37 indexed citations
16.
Brock, James A., Osama F. Harraz, Ashley I. Bush, et al.. (2021). Zinc drives vasorelaxation by acting in sensory nerves, endothelium and smooth muscle. Nature Communications. 12(1). 3296–3296. 36 indexed citations
17.
Ayton, Scott & Ashley I. Bush. (2021). beta-amyloid: The known unknowns. Ageing Research Reviews. 65. 2 indexed citations
18.
Lei, Peng, Scott Ayton, & Ashley I. Bush. (2020). The essential elements of Alzheimer’s disease. Journal of Biological Chemistry. 296. 100105–100105. 217 indexed citations breakdown →
19.
Redvers, Richard P., Scott Ayton, Irmina Diala, et al.. (2019). Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis. Breast Cancer Research. 21(1). 94–94. 122 indexed citations
20.
Furtado, Denzil, Mattias Björnmalm, Scott Ayton, et al.. (2018). Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases. Advanced Materials. 30(46). e1801362–e1801362. 525 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James A. Duce Breakdown of academic impact, for papers by Zvonimir S. Katušić Breakdown of academic impact, for papers by Irene Volitakis Breakdown of academic impact, for papers by Jack T. Rogers Breakdown of academic impact, for papers by Masatsugu Horiuchi Breakdown of academic impact, for papers by Robert D. Bell Breakdown of academic impact, for papers by Junxia Xie Breakdown of academic impact, for papers by Mark A. Lovell Breakdown of academic impact, for papers by Zhong‐Ming Qian Breakdown of academic impact, for papers by Ya Ke
Rankless by CCL
2026